About STATICH

STATICH is an investigator-led, randomised-controlled, open, blinded end-point (PROBE) clinical trial of antithrombotic treatment for prevention of ischemic events after intracerebral haemorrhage.

The trial sponsor is Oslo University Hospital in Norway. The trial co-ordinating center is Oslo University Hospital in collaboration with Akershus University Hospital.

For information about the background and methods, please see the protocol summary or the full protocol under “Documents”.



Contact information


STATICH Co-ordinating Centre
Oslo University Hospital, Ullevål
Department of Geriatric Medicine, Building 20, 4th floor
P.O. Box 4950 Nydalen
NO-0424 Oslo
Norway

Tel./fax: +47 22 11 99 11/12

Trial Manager
Kristin Tveitan Larsen
k.t.larsen(a)medisin.uio.no


Trial Co-ordinating Investigator (in Norway)
Eivind Berge
eivind.berge(a)medisin.uio.no


MRI Sub-study Investigator
Ole Morten Rønning
o.m.ronning(a)medisin.uio.no


National Co-ordinating Investigator in Sweden
Johanna Pennlert
johanna.pennlert(a)umu.se

Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden


National Co-ordinating Investigator in Sweden
Eva-Lotta Glader
eva-lotta.glader(a)umu.se

Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden


National Co-ordinating Investigator in Denmark
Christina Kruuse
christina.kruuse(a)regionh.dk

Dept. of Neurology, Stroke Unit N108
Herlev Gentofte Hospital
Herlev Ringvej 75
DK-2730 Herlev
Denmark